<DOC>
	<DOCNO>NCT02311231</DOCNO>
	<brief_summary>In trial test hypothesis PCI bivalirudin superior heparin alone ( accord local protocol ) reduce death , MI , major bleed patient NSTEMI STEMI 180 day ( primary end point ) , treat ticagrelor prasugrel .</brief_summary>
	<brief_title>Bivalirudin v Heparin NSTEMI STEMI Patients Modern Antiplatelet Therapy SWEDEHEART</brief_title>
	<detailed_description>The follow endpoint perform use SWEDEHEART national registry . Follow primary endpoint stroke also perform telephone contact patient first degree relative nurse phone call 7 day 180 day . The nurse also accumulate hospital record information endpoint . A central adjudication perform report primary endpoint first 180 day follow . Every site prepare source document event send UCR central adjudication independent committee .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Bivalirudin</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Hirudins</mesh_term>
	<criteria>Patients diagnosis NSTEMI judge physician accordance current guideline definition ( positive troponin ) , patient diagnosis STEMI define chest pain suggestive myocardial ischemia least 30 minute hospital admission , time onset symptom less 24 hour , ECG new STsegment elevation two contiguous lead ≥0.2 mV lead V2V3 and/or ≥0.1 mV lead probable newonset leave bundle branch block . PCI culprit lesion intend ( therapeutic PCI , primarily diagnostic PCI ) . Treated bolus dose ticagrelor prasugrel start PCI . See 2.6 Ability provide inform consent Age 18 year older Previous randomization VALIDATESWEDEHEART trial . Known terminal disease life expectancy le one year . Patients know ongoing bleeding Patients uncontrolled hypertension opinion investigator Patients know subacute bacterial endocarditis Patients know severe renal ( GFR &lt; 30 ml/min ) and/or liver dysfunction Patients know thrombocytopenia thrombocyte function defect Any contraindication study medication . Heparin &gt; 5000U Before arrive PCI lab &gt; 3000 U give angiography randomization . GpIIb/IIIa inhibitor give preplanned give procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>